Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 31,418 | 25,640 | 19,819 | 17,292 | 12,800 |
| Operating Income | -31,418 | -25,640 | -19,819 | -17,292 | -12,800 |
| Other Income | 784 | 728 | 735 | 743 | 1,072 |
| Pre-tax Income | -30,634 | -24,912 | -19,084 | -16,549 | -11,728 |
| Net Income Continuous | -30,634 | -24,912 | -19,084 | -16,549 | -11,728 |
| Net Income | $-30,634 | $-24,912 | $-19,084 | $-16,549 | $-11,728 |
| EPS Basic Total Ops | -0.68 | -0.62 | -0.48 | -0.43 | -0.34 |
| EPS Basic Continuous Ops | -0.68 | -0.62 | -0.48 | -0.43 | -0.34 |
| EPS Diluted Total Ops | -0.68 | -0.62 | -0.48 | -0.43 | -0.34 |
| EPS Diluted Continuous Ops | -0.68 | -0.62 | -0.48 | -0.43 | -0.34 |
| EBITDA(a) | $-31,349 | $-25,572 | $-19,771 | $-17,278 | $-12,783 |